Barbara Ryan, Director at Indivior Pharmaceuticals, Inc. (INDV), bought 31 shares at $32.56 ($1K) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Open-market purchase of $1k INDV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| INKT | SELL | 2026-03-11 | $36K | — | Filing → |
| INKT | SELL | 2026-03-04 | $5K | — | Filing → |
| INDV | BUY | 2026-01-07 | $27K | — | Filing → |